Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Myeloid, Chronic-Phase × Afatinib × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 32 Neoplasms 8 Breast Neoplasms 8 Head and Neck Neoplasms 4 Lung Neoplasms 3 Carcinoma, Squamous Cell 3 Adenocarcinoma 3 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Neoplasm Metastasis 2 Urologic Neoplasms 1 Urinary Bladder Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Thoracic Neoplasms 1 Squamous Non-small Cell Lung Cancer 1 Squamous Cell Cancers of the Head and Neck 1 Rhabdomyosarcoma 1 Respiratory Tract Neoplasms 1 Respiratory Tract Diseases 1 Prostatic Neoplasms 1 Pleural Neoplasms 1 Pleural Effusion, Malignant 1 Pleural Effusion 1 Pleural Diseases 1 Neuroectodermal Tumors 1 Neoplasms by Site 1 Multiple Myeloma 1 Lymphoma 1 Lung Diseases 1

Interventions

fludarabine phosphate 27 Cyclophosphamide 23 Whole-Body Irradiation 22 Peripheral Blood Stem Cell Transplantation 21 Mycophenolic Acid 21 Cyclosporine 18 Busulfan 18 Tacrolimus 15 Imatinib Mesylate 12 Antilymphocyte Serum 12 Methotrexate 11 Melphalan 10 Dasatinib 10 Cord Blood Stem Cell Transplantation 10 Cyclosporins 8 Etoposide 7 nilotinib 6 Radiotherapy 6 Methylprednisolone 6 Filgrastim 6 Sirolimus 5 Alemtuzumab 5 thymoglobulin 4 bosutinib 4 Granulocyte Colony-Stimulating Factor 4 Cytarabine 4 fludarabine 3 Thiotepa 3 Rituximab 3 Flow Cytometry 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡